Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hetrombopag for Chemotherapy-Induced Thrombocytopenia in Lung Cancer
NCT07101627Phase 2Not yet recruiting
- Sponsor
- Shanghai Pulmonary Hospital
- Start
- Aug 2025
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hetrombopag in Thrombocytopenia, sponsored by Shanghai Pulmonary Hospital. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
hetrombopag
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT07101627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07101627.